semaglutide for insulin resistance does increase Semaglutide-Mediated Remodeling of Adipose Tissue in Type 2 Diabetes: Molecular Your Body Isn't Broken: How

The phase 2 trial published in the New England Journal of Medicine in 2023 enrolled 338 adults with obesity or overweight plus comorbidities

This should be considered when treating patients, with impaired renal function as nausea, vomiting, and diarrhoea may cause dehydration which could cause a deterioration of renal function

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate consistent risk reductions for mortality, myocardial infarction, stroke, heart failure, and renal outcomes, irrespective of their effects on glycemia

Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy and Ozempic